The Senior Medical Officer will be responsible for a range of clinical trial activities of PATH’s CVIA, including lead roles in development of clinical research plans (from phase 1 through post-marketing), vaccine introduction plans, pharmacovigilance, development of protocols and related documents (IC, CRFs, CSRs, etc.) and oversight of their implementation.
PATH is a global organization that works to accelerate health equity by bringing together public institutions, businesses, social enterprises, and investors to solve the world’s most pressing health challenges. With expertise in science, health, economics, technology, advocacy, and dozens of other specialties, PATH develops and scales solutions—including vaccines, drugs, devices, diagnostics, and innovative approaches to strengthening health systems worldwide.
PATH’s Center for Vaccine Innovation and Access brings together our expertise across every stage of the long and complex process of vaccine research, development, and delivery to make lifesaving vaccines widely available to children and communities across the world. CVIA’s current portfolio encompasses more than two dozen vaccines either in development or already in use to protect against 15 different diseases. Our focus is on vaccines to address the leading diseases that claim children’s lives worldwide: pneumonia, diarrheal disease, and malaria; as well as other global health priorities, such as polio and meningitis. We work in partnership with national health ministries, pharmaceutical manufacturers, donors, international financing and regulatory organizations, and many others. PATH has led numerous global partnerships, including the award-winning Meningitis Vaccine Project and the Malaria Vaccine Initiative, which helped develop the first malaria vaccine candidate recommended for pilot implementation.
- Plans and participates in the implementation of a broad portfolio of clinical research that evaluates a wide range of novel vaccine candidates of importance in developing countries.
- Serves as medical officer for CVIA clinical trials, being responsible for leading, managing, and coordinating clinical trials of candidate vaccines, all the way from Phase 1 through post-marketing studies.
- Participates in the selection of clinical sites and CROs, including site visits to evaluate and identify needs and gaps of potential clinical sites.
- Reviews of clinical laboratory activities to insure proper handling and testing of specimens.
- Participates in the development and/or review of protocols and ICDs, CRFs, SOPs and other documents.
- Reviews clinical sites pharmacy plans and activities.
- Troubleshoots issues of operational compliance or other problems impacting trials progress/quality.
- Oversees of protocol implementation, including safety oversight, pharmacovigilance and ethical compliance.
- Provides leadership and medical expertise in the planning and implementation of CVIA-supported vaccine clinical trials and related activities (e.g., epidemiological studies, vaccine preparedness studies, effectiveness studies, post-marketing pharmacovigilance, development and validation of new diagnostic tools and immunological assays on-site training of key staff, etc.).
- Monitors clinical trial progress, relevance and merit.
- Determines the need for and/or makes site visits to plan and on site evaluate clinical trial efforts; initiates appropriate action when research progress is inadequate.